GetTopicDetailResponse(id=cf1f125350b5, topicName=免疫抑制劑（IST）, introduction=, content=免疫抑制劑（IST）, image=null, comments=0, allHits=93, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Mar 22 18:01:23 CST 2025, time=2025-03-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=502760, tagList=[TagDto(tagId=502760, tagName=免疫抑制劑（IST）)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2257289, encodeId=cb16225e289e1, content=<a href='/topic/show?id=cf1f125350b5' target=_blank style='color:#2F92EE;'>#免疫抑制劑（IST）#</a>, objectTitle=ACR Open Rheumatol：不同免疫抑制劑對彌漫性硬皮病皮膚病變和肺功能的治療效果比較, objectType=article, longId=868334, objectId=0a12868334c4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719492639164_2570354.png, objectUrl=/article/show_article.do?id=0a12868334c4, replyNumber=0, likeNumber=26, createdTime=2025-03-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=0a12868334c4, moduleTitle=ACR Open Rheumatol：不同免疫抑制劑對彌漫性硬皮病皮膚病變和肺功能的治療效果比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0a12868334c4)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-03-22發(fā)表于陜西省
